Literature DB >> 17479518

Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease.

Huaiyu Hu1, Yuan Yang, Amber Eade, Yufang Xiong, Yue Qi.   

Abstract

Neuronal overmigration is the underlying cellular mechanism of cerebral cortical malformations in syndromes of congenital muscular dystrophies caused by defects in O-mannosyl glycosylation. Overmigration involves multiple developmental abnormalities in the brain surface basement membrane, Cajal-Retzius cells, and radial glia. We tested the hypothesis that breaches in basement membrane and the underlying glia limitans are the key initial events of the cellular pathomechanisms by carrying out a detailed developmental study with a mouse model of muscle-eye-brain disease, mice deficient in O-mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1). The pial basement membrane was normal in the knockout mouse at E11.5. It was breached during rapid cerebral cortical expansion at E13.5. Radial glial endfeet, which comprise glia limitans, grew out of the neural boundary. Neurons moved out of the neural boundary through these breaches. The overgrown radial glia and emigrated neurons disrupted the overlying pia mater. The overmigrated neurons did not participate in cortical plate (CP) development; rather they formed a diffuse cell zone (DCZ) outside the original cortical boundary. Together, the DCZ and the CP formed the knockout cerebral cortex, with disappearance of the basement membrane and the glia limitans. These results suggest that disappearance of the basement membrane and the glia limitans at the cerebral cortical surface during development underlies cortical lamination defects in congenital muscular dystrophies and a cellular mechanism of cortical malformation distinct from that of the reeler mouse, double cortex syndrome, and periventricular heterotopia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479518

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  8 in total

1.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

Review 2.  Abnormal development of the human cerebral cortex.

Authors:  Waney Squier; Anna Jansen
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

3.  Mutation of the BiP/GRP78 gene causes axon outgrowth and fasciculation defects in the thalamocortical connections of the mammalian forebrain.

Authors:  Carlita B Favero; Rasha N Henshaw; Cynthia M Grimsley-Myers; Ayushma Shrestha; David R Beier; Noelle D Dwyer
Journal:  J Comp Neurol       Date:  2013-02-15       Impact factor: 3.215

4.  GPR56-regulated granule cell adhesion is essential for rostral cerebellar development.

Authors:  Samir Koirala; Zhaohui Jin; Xianhua Piao; Gabriel Corfas
Journal:  J Neurosci       Date:  2009-06-10       Impact factor: 6.167

Review 5.  Polymicrogyria: pathology, fetal origins and mechanisms.

Authors:  Waney Squier; Anna Jansen
Journal:  Acta Neuropathol Commun       Date:  2014-07-22       Impact factor: 7.801

6.  Human embryoid bodies as a 3D tissue model of the extracellular matrix and α-dystroglycanopathies.

Authors:  Alec R Nickolls; Michelle M Lee; Kristen Zukosky; Barbara S Mallon; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2020-06-26       Impact factor: 5.758

7.  TMEM216 Deletion Causes Mislocalization of Cone Opsin and Rhodopsin and Photoreceptor Degeneration in Zebrafish.

Authors:  Yu Liu; Shuqin Cao; Miao Yu; Huaiyu Hu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-07-01       Impact factor: 4.799

Review 8.  The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.

Authors:  Alec R Nickolls; Carsten G Bönnemann
Journal:  Dis Model Mech       Date:  2018-12-19       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.